学習ガイド
ペプチドとGLP-1を記録するための実践ガイド。落ち着いた臨床的な視点で、押しつけのない情報をお届けします。
コンテンツの言語：English
How to build a supplement tracker that works: read the Supplement Facts panel, record each product properly, group your stack by time of day, spot overlaps, and keep a taken-or-skipped log.
記事を読むA practical system for keeping one accurate list of your prescriptions, over-the-counter medicines, vitamins and supplements, with reminders and a taken-or-skipped log you can bring to appointments.
What "take with food", "before food", "after food" and "on an empty stomach" usually mean on a medicine or supplement label, why the instructions exist, and how to fit them into a daily routine.
A fair comparison of pill and medication reminder apps in 2026, including Medisafe, MyTherapy, Max, EveryDose, CareClinic, Doz and TrackPep, with the checklist that matters and who each app suits.
What a 2025 joint advisory from four US medical and nutrition societies says about nutrients during GLP-1 therapy, the supplements people commonly ask their clinicians about, and a simple way to track them next to your injections.
Moving between semaglutide and tirzepatide? Here is what to log for the first 8 weeks, how to compare before and after fairly, and what to ask your prescriber, with no dose conversion.
A fair guide to GLP-1 tracker apps for Ozempic, Wegovy, Mounjaro and Zepbound users: the checklist a good app must meet, plus a comparison of TrackPep, Shotsy, PeptIQ and Regimen.
A 2026 Cambridge review of 48 studies found about 60 percent of lost weight came back within a year of stopping. Here is what that means, and what to log so you and your clinician can see regain early.
Stalled scale on semaglutide or tirzepatide? Learn how to tell a true plateau from normal fluctuation, what to log, and when to bring the data to your prescriber.
Missed a GLP-1 injection? Don't guess. Here is what to write down right away, the questions to bring to your prescriber, and how a clean log makes that call faster.
A 2026 Penn Medicine study in The BMJ linked GLP-1 drugs to more hair-loss diagnoses. Here is what it found, why shedding happens, and what to log for your clinician.
The Wegovy pill and Lilly's Foundayo (orforglipron) are daily tablets, not weekly pens. Here is what has been reported so far, and what a good log looks like when the routine is every morning instead of every week.
Five workout trackers compared on what each is actually built for, sourced from the vendors' own pages — including where we could not verify a free-tier limit, and where TrackPep is the wrong tool.
Total daily energy expenditure broken into its four components, the Mifflin-St Jeor equation the calculators actually run, and the published evidence on how far a prediction can sit from a measurement.
Published error ranges for AI food-photo estimation, why portion size — not food recognition — is the weak link, and the shooting habits that measurably narrow the gap.
What the SURMOUNT-1 and STEP 1 body-composition data actually show about lean-mass loss, why the size of the deficit matters as much as the training, and a plain 3-day full-body template built on public guidelines.
The published protein range for weight loss, the study that found most GLP-1 users fall short of it, and how to turn a per-kilogram number into meals — with every figure cited to the paper it came from.
Monthly headline prices hide what you actually spend. Here is the arithmetic for cost per dose and per month, why wastage matters more than the price tier, and how to keep the number without a spreadsheet.
A checklist of the things a patient can independently check about a compounded GLP-1 prescription — pharmacy licence, facility type, ingredient form, prescriber licensure, and testing — with what each one does and does not prove.
The shortage ended, compounding rules tightened, the FDA sent two waves of warning letters, and Lilly went to court — while advertised compounded prices fell. A dated timeline of what changed and what it means.
The Wegovy pill was approved in December 2025 and launched at a lower self-pay price than the pen. Here is what Novo Nordisk publishes for each form, tier by tier, and where the two lines cross.
Zepbound and Mounjaro are both tirzepatide, priced differently because they are approved for different conditions. Here is what Lilly publishes for each, and why your insurance treats them as separate drugs.
What semaglutide costs in 2026 — Ozempic's published list price, NovoCare self-pay pricing for Wegovy pen and pill, savings-card floors, and the $675 list price arriving in January 2027.
What tirzepatide actually costs in 2026 — Zepbound and Mounjaro self-pay prices from Lilly, savings-card floors, and advertised compounded telehealth pricing — each quoted from the source that published it.
A dated comparison of what GLP-1 medications actually cost in 2026 — brand list price, manufacturer self-pay, insurance copay, and compounded telehealth — with every figure quoted from the company that published it.
A fair comparison of the peptide and GLP-1 tracking apps available in 2026 — TrackPep, Regimen, PeptIQ, Shotsy and others — by platform, compound support, calculators and price.
Convert between syringe units, millilitres and milligrams on U-100, U-50 and U-40 insulin syringes. Printed conversion tables for every common dose, plus the one formula that ties them together.
On July 23 to 24, 2026, an FDA advisory committee voted to recommend BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax for pharmacy compounding, and voted against Emideltide (DSIP). The vote is not FDA approval — here is what changed and what did not.
再構成でよくある疑問：静菌水を多く加えると、より多い用量を摂取することになるのか？答えはノーですが、加える量自体は重要です。数学で明快に解説します。
空腹時に注射すべきか、食後にすべきか？答えは化合物によって完全に異なります。ペプチドクラス別の経験則と、なぜ一部には重要で他には重要でないのかを解説します。
最も議論される修復ペプチドの組み合わせを解説：組み合わせの根拠、リサーチ化合物に関する注意点、データを混乱させずにスタックを記録する方法。
一般的なペプチド・GLP-1プロトコルのためのベースラインおよびフォローアップ検査の実用ガイド：何を測定するか、なぜか、そして結果を用量記録とどう照合するか。
この2つの成長ホルモンペプチドは常に比較されますが、異なる役割を持ち、選択するというよりむしろ組み合わせて使われることが多いです。
最も議論されている3つのGLP-1化合物を平易に比較：受容体、半減期、漸増スケジュールの違いと、それぞれ何を記録すべきか。
Huberman Lab のペプチドマスタークラス（Dr. Abud Bakri 出演）を、科学に基づき明快に整理：BPC-157、Epithalon、胸腺ペプチド、GHK-Cu、GLP-1、retatrutide、調達リスク、重要な検査、そしてなぜ注目が爆発したのか。教育目的のみ。
プロトコルの途中でバイアルが切れたり、期限切れの BAC water を使ったりするのは避けられるミスです。プロトコルを円滑に回す在庫システムの作り方を学びましょう。
旅行中もプロトコルを守るには計画が必要です。ペプチドを適温で保管し、保安検査を通過し、時間帯をまたいで用量を記録する方法を学びましょう。
脱水は吐き気や頭痛などの GLP-1 副作用を増幅させます。日々の水分摂取を追跡し、プロトコルと並べて水分補給のパターンを見つける方法を学びましょう。
バイアルあたりの mg と BAC water をシリンジの units に変換する方法を、semaglutide と tirzepatide の実例つきで解説します。教育目的 — 医療上の助言ではありません。
BAC water とは何か、滅菌水とどう違うのか、どう保管するのか、そして最もよく寄せられる質問への回答。
紛らわしいシリンジの目盛りは10倍の過量投与につながりかねません。毎回正しくシリンジを読む方法を学びましょう。
静菌水は永遠に無菌ではありません。保管方法、交換時期、汚染が疑われる場合の対処を学びましょう。
ペプチドプロトコルで最も一般的な用量ミスは、U-100 の目盛りを U-40 のように（またはその逆に）読むことです。それを絶対にしない方法を紹介します。
複数のペプチドをスタックすることは研究プロトコルで一般的です。どの組み合わせが相乗的か、どれが冗長になりうるか、そしてすべてをきれいに追跡する方法を学びましょう。
体重計の数値は日々変動します。GLP-1 プロトコルが実際に効いているかを見極めるため、シグナルとノイズを分ける方法を学びましょう。
semaglutide（Ozempic、Wegovy、または調製品）を使う人のための実用的な記録テンプレート。何を追跡し、何がノイズで、どうパターンを見つけるか。
半減期は化合物が体内で活性を保つ時間を決めます。それを理解すると、より賢く投与でき、蓄積を避けられます。
注射部位のローテーションはリポハイパートロフィーを防ぎ、吸収の一貫性を高めます。ローテーションの習慣を作る完全ガイドです。
吐き気、倦怠感、注射部位反応は GLP-1 療法でよく見られます。構造化された記録が、あなたと医師の管理に役立ちます。
どのペプチドバイアルにも正しい BAC water 量と用量を計算する方法を学びましょう。自信を持って投与できるよう、計算を順を追って説明します。
